14 results
DEF 14A
CYT
Cyteir Therapeutics Inc
29 Apr 22
Definitive proxy
1:49pm
is qualified to serve on our Board of Directors because of his extensive experience in drug development and his leadership experience … strategist and entrepreneur with more than 25 years of experience advising CEOs and their leadership teams in the areas of strategy, commercial
10-K
2021 FY
CYT
Cyteir Therapeutics Inc
16 Mar 22
Annual report
4:08pm
agencies caused by funding shortages or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel
8-K
EX-99.1
CYT
Cyteir Therapeutics Inc
11 Jan 22
Regulation FD Disclosure
8:01am
Paul Secrist, PhD Jean-Marc Lapierre, PhD Chief Scientific Officer VP, Chemistry Cyteir Leadership Tom O’Shea, PhD Gale Cohen SVP, Clinical … Pharmacology and VP, Human Resources Preclinical Development Susan Doleman Barbara Wan, PhD VP, Clinical Operations VP, Research & Development Project Leadership
424B4
mpa17w ddqxyn4
21 Jun 21
Prospectus supplement with pricing info
6:13am
S-1/A
rcfhwiqxm3tnov vz
4 Jun 21
IPO registration (amended)
4:32pm
S-1
EX-10.9
3qn5mi8r2t2d938q
28 May 21
IPO registration
4:01pm
S-1
EX-10.10
vnv7yq
28 May 21
IPO registration
4:01pm
S-1
wvp3 apnl1ets05
28 May 21
IPO registration
4:01pm
DRS/A
w0gbqbz1n0v84dffit
14 May 21
Draft registration statement (amended)
12:00am
DRS/A
5ycrzaccb3y6g9r
30 Apr 21
Draft registration statement (amended)
12:00am
DRS
l9ccda
26 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next